Search research articles
Contact Us
Filters
Showing results (21-30 of 128) with videos related to
Page
of 13
Sort By:
Journal of Medical Economics
|
May 19, 2015
Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression
Krithika Rajagopalan, Kellie Meyer, Ken O'Day, et al.
International Clinical Psychopharmacology
|
October 6, 2007
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study
Dan Zimbroff, Lewis Warrington, Antony Loebel, et al.
Annals of the New York Academy of Sciences
|
January 16, 2016
The development of lurasidone for bipolar depression
Antony Loebel, Jane Xu, Jay Hsu, et al.
Innovations in Clinical Neuroscience
|
February 8, 2018
Understanding Antipsychotic Drug Treatment Effects: A Novel Method to Reduce Pseudospecificity of the Positive and Negative Syndrome Scale (PANSS) Factors
Seth C Hopkins, Ajay Ogirala, Antony Loebel, et al.
Psychopharmacology
|
June 20, 2006
The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements
Philip D Harvey, Michael F Green, Christopher Bowie, et al.
BMC Health Services Research
|
April 6, 2018
Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis
John W Newcomer, Daisy Ng-Mak, Krithika Rajagopalan, et al.
International Journal of Methods in Psychiatric Research
|
June 27, 2018
Ratings surveillance and reliability in a study of major depressive disorder with subthreshold hypomania (mixed features)
Steven D Targum, J Cara Pendergrass, Sang Lee, et al.
Journal of Comparative Effectiveness Research
|
April 27, 2018
Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis
Daisy Ng-Mak, Vanita Tongbram, Kerigo Ndirangu, et al.
Human Psychopharmacology
|
September 10, 2013
Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies
Sheldon Preskorn, Larry Ereshefsky, Yu-Yuan Chiu, et al.
Clinical Therapeutics
|
January 6, 2016
Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis
Sunny Chapel, Yu-Yuan Chiu, Jay Hsu, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 128) with videos related to
Sort By:
Page
of 13
Journal of Medical Economics
|
May 19, 2015
Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression
Krithika Rajagopalan, Kellie Meyer, Ken O'Day, et al.
International Clinical Psychopharmacology
|
October 6, 2007
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study
Dan Zimbroff, Lewis Warrington, Antony Loebel, et al.
Annals of the New York Academy of Sciences
|
January 16, 2016
The development of lurasidone for bipolar depression
Antony Loebel, Jane Xu, Jay Hsu, et al.
Innovations in Clinical Neuroscience
|
February 8, 2018
Understanding Antipsychotic Drug Treatment Effects: A Novel Method to Reduce Pseudospecificity of the Positive and Negative Syndrome Scale (PANSS) Factors
Seth C Hopkins, Ajay Ogirala, Antony Loebel, et al.
Psychopharmacology
|
June 20, 2006
The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements
Philip D Harvey, Michael F Green, Christopher Bowie, et al.
BMC Health Services Research
|
April 6, 2018
Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis
John W Newcomer, Daisy Ng-Mak, Krithika Rajagopalan, et al.
International Journal of Methods in Psychiatric Research
|
June 27, 2018
Ratings surveillance and reliability in a study of major depressive disorder with subthreshold hypomania (mixed features)
Steven D Targum, J Cara Pendergrass, Sang Lee, et al.
Journal of Comparative Effectiveness Research
|
April 27, 2018
Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis
Daisy Ng-Mak, Vanita Tongbram, Kerigo Ndirangu, et al.
Human Psychopharmacology
|
September 10, 2013
Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies
Sheldon Preskorn, Larry Ereshefsky, Yu-Yuan Chiu, et al.
Clinical Therapeutics
|
January 6, 2016
Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis
Sunny Chapel, Yu-Yuan Chiu, Jay Hsu, et al.
Page
of 13